029
THE LAB
SECTION 11
ISSUE 001
OBSERVEDresearchnowconfidence / high
Triage the Regulatory Genome
Sequence-to-function models are expanding analysis of long-range regulatory context. Build a clinical research layer that ranks non-coding variants by predicted mechanism, ancestry-aware uncertainty, and experimentability, then routes the highest-value candidates to functional assays while presenting model scores as research evidence rather than diagnoses.
Why this idea is here
What the evidence establishes.
AlphaGenome targets non-coding variant effects; NIH’s data strategy prioritizes multimodal, reusable biomedical data and responsible methods.
Source ledger
Read the sources.
- S01Predicting Non-Coding Variant Effects with AlphaGenome
peer-reviewed research highlight / published 2026-04-08 / retrieved 2026-07-09
- S02NIH Strategic Plan for Data Science 2025–2030
official strategy / dated 2025-05 / retrieved 2026-07-09